Li YS - Search Results

1

Analgesic Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Advanced Non-Small-Cell Lung Cancer: A Randomized, Sham-Controlled, Pilot Study.

Tang Y, Chen H, Zhou Y, Tan ML, Xiong SL, Li Y, Ji XH, Li YS. Tang Y, et al. Among authors: li y, li ys. Front Oncol. 2022 Mar 17;12:840855. doi: 10.3389/fonc.2022.840855. eCollection 2022. Front Oncol. 2022. PMID: 35372024 Free PMC article.

2

Efficacy and safety of original EGFR-TKI combined with bevacizumab in advanced lung adenocarcinoma patients harboring EGFR-mutation experiencing gradual progression after EGFR-TKI treatment: a single-arm study.

Long J, Lei S, Wu Z, Xiong S, Wang C, Huang L, Liang G, Yang D, Teng Y, Li Y, Qi J, Li D. Long J, et al. Ann Transl Med. 2022 Dec;10(24):1334. doi: 10.21037/atm-22-6101. Ann Transl Med. 2022. PMID: 36660644 Free PMC article.

3

Comparison of survival outcomes between clinical trial participants and non-participants of patients with advanced non-small cell lung cancer: A retrospective cohort study.

Jiang Q, Yue X, Lei H, Mao W, Li Y, Chen X. Jiang Q, et al. Heliyon. 2023 Nov 20;9(12):e22660. doi: 10.1016/j.heliyon.2023.e22660. eCollection 2023 Dec. Heliyon. 2023. PMID: 38076123 Free PMC article.

4

Successful Treatment of Switching EGFR-TKIs for Advanced Lung Adenocarcinoma Due to Interstitial Lung Disease: A Case Report.

Zeng X, Wang T, Tang Y, Liao X, Wang J, Li Y. Zeng X, et al. Curr Cancer Drug Targets. 2024 Jul 5. doi: 10.2174/0115680096313868240603090903. Online ahead of print. Curr Cancer Drug Targets. 2024. PMID: 38982693

5

Ding Y, Lei S, Wang L, Tang L, Zhang Y, Liao Y, Deng X, Li Y, Gong Y, Li Y. Ding Y, et al. Lung Cancer. 2024 Sep;195:107925. doi: 10.1016/j.lungcan.2024.107925. Epub 2024 Aug 8. Lung Cancer. 2024. PMID: 39146625

6

Identification and prediction of immune checkpoint inhibitors-related pneumonitis by machine learning.

Gong L, Gong J, Sun X, Yu L, Liao B, Chen X, Li YS. Gong L, et al. Among authors: li ys. Front Immunol. 2023 Jun 29;14:1138489. doi: 10.3389/fimmu.2023.1138489. eCollection 2023. Front Immunol. 2023. PMID: 37457722 Free PMC article.

7

Editorial: Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies.

Leavenworth JW, Lai X, Miao H, Wang D, Zhao H, Li Y. Leavenworth JW, et al. Front Immunol. 2022 Dec 16;13:1113031. doi: 10.3389/fimmu.2022.1113031. eCollection 2022. Front Immunol. 2022. PMID: 36591256 Free PMC article. No abstract available.

8

Protein S-palmitoylation modification: implications in tumor and tumor immune microenvironment.

Chen Y, Li Y, Wu L. Chen Y, et al. Front Immunol. 2024 Feb 13;15:1337478. doi: 10.3389/fimmu.2024.1337478. eCollection 2024. Front Immunol. 2024. PMID: 38415253 Free PMC article. Review.

9

Fibroblast growth factor signaling in macrophage polarization: impact on health and diseases.

Shen L, Li Y, Zhao H. Shen L, et al. Front Immunol. 2024 Jun 19;15:1390453. doi: 10.3389/fimmu.2024.1390453. eCollection 2024. Front Immunol. 2024. PMID: 38962005 Free PMC article. Review.

10

DNASE1L3-mediated PANoptosis enhances the efficacy of combination therapy for advanced hepatocellular carcinoma.

Wang J, Chen Y, Xu Y, Zhang J, Yang S, Zhou Y, Lei J, Ren R, Chen Y, Zhao H, Li Y, Yang S. Wang J, et al. Theranostics. 2024 Oct 14;14(17):6798-6817. doi: 10.7150/thno.102995. eCollection 2024. Theranostics. 2024. PMID: 39479454 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,789 results

Search Page

Filters